NK and NKT cell functions in immunosenescence

Aging Cell - Tập 3 Số 4 - Trang 177-184 - 2004
Eugenio Mocchegiani1, Marco Malavolta1
1Immunology Centre (Section Nutrition, Immunity and Aging), Research Department INRCA, Ancona, Italy

Tóm tắt

SummaryImmunosenescence is defined as the state of dysregulated immune function that contributes to the increased susceptibility to infection, cancer and autoimmune diseases observed in old organisms, including humans. However, dysregulations in the immune functions are normally counterbalanced by continuous adaptation of the body to the deteriorations that occur over time. These adaptive changes are likely to occur in healthy human centenarians. Both innate (natural) and adaptive (acquired) immune responses decline with advancing age. Natural killer (NK) and natural killer T (NKT) cells represent the best model to describe innate and adaptive immune response in aging. NK and NKT cell cytotoxicity decreases in aging as well as interferon‐γ (IFN‐γ) production by both activated cell types. Their innate and acquired immune responses are preserved in very old age. However, NKT cells bearing T‐cell receptor (TCR) γδ also display an increased cytotoxicity and IFN‐γ production in very old age. This fact suggests that NKT cells bearing TCRγδ are more involved in maintaining innate and adaptive immune response in aging leading to successful aging. The role played by the neuroendocrine–immune network and by nutritional factors, such as zinc, in maintaining NK and NKT cell functions in aging is discussed.

Từ khóa


Tài liệu tham khảo

10.1034/j.1600-0528.2002.017415.x

10.1073/pnas.80.20.6371

10.1002/eji.200324151

Argentati K, 2000, Induction of natural killer cell activity and perforin and granzyme B gene expression following continuous culture of short pulse with interleukin‐12 in young and old mice, Eur. Cytokine Netw., 11, 59

10.1189/jlb.72.1.65

10.1146/annurev.immunol.15.1.535

10.1016/S0952-7915(00)00241-7

10.1016/S0531-5565(98)00076-X

10.3109/08923979409007097

10.1038/sj.ejcn.1601492

10.1016/S0531-5565(01)00185-1

10.1126/science.278.5343.1623

10.1093/jn/129.10.1782

10.1016/S0531-5565(01)00186-3

10.1016/S1471-4906(03)00162-5

10.1053/jhep.2001.23504

10.1007/BF02983234

Franceschi C, 2000, Do men and women follow different trajectories to reach extreme longevity? Italian Multicenter Study on Centenarians (IMUSCE), Aging (Milano), 12, 77

10.1083/jcb.200212143

10.4049/jimmunol.169.11.6127

10.1006/cimm.1999.1483

10.1016/0008-8749(92)90221-A

10.1016/S0047-6374(97)00045-6

10.1016/0165-2478(96)02519-9

10.1006/cimm.1994.1112

10.1146/annurev.immunol.16.1.359

10.1016/S0531-5565(03)00058-5

10.1002/1521-4141(200206)32:6<1524::AID-IMMU1524>3.0.CO;2-E

10.1046/j.1365-2249.1999.00855.x

10.1111/j.1365-2249.1990.tb05359.x

10.1016/S0047-6374(96)01829-5

10.1016/S0198-8859(00)00153-1

10.1016/j.exger.2004.01.014

MocchegianiE GiacconiR MutiE MuzzioliM CiprianoC(2004b)Plasticity of neuroendocrine–thymus interactions during ontogeny and aging: role of zinc. In:Neuroimmunebiology ‘the Neuroendocrine Immune Network in Aging’(StraubR MocchegianiE eds) Vol.4. Amsterdam:Elsevier pp.305–327.

10.1016/S0047-6374(98)00115-8

10.1016/S0165-6147(00)01476-0

10.1016/S0047-6374(03)00023-X

10.1016/0192-0561(95)00059-B

10.1046/j.1365-2567.1997.00343.x

10.1006/clin.1997.4401

10.1084/jem.180.2.699

10.1046/j.1365-2362.2000.00729.x

Pawelec G, 1999, Immunosenescence: impact in the young as well as the old?, Mech. Aging Dev., 108, 1

10.1016/j.coi.2004.01.011

10.1084/jem.20011544

10.1016/S0167-5699(98)01266-3

10.1006/cyto.1997.0265

10.1016/0531-5565(89)90014-4

10.1016/S0047-6374(97)00153-X

10.1182/blood.V92.7.2410

10.1111/j.1749-6632.1992.tb38717.x

Schwartz RN, 2002, Managing toxicities of high‐dose interleukin‐2, Oncology, 16, 11

10.1016/S0264-410X(99)00495-8

10.1016/S0047-6374(01)00289-5

10.1385/IR:27:2-3:539

10.1146/annurev.immunol.21.120601.141057

10.1038/ni1203-1164

10.1189/jlb.0303097

10.1016/S0074-7696(08)62169-5

10.1038/nri911

10.1002/hep.510260208

Watanabe H, 1995, Relationships between intermediate TCR cells and NK1.1+ T cells in various immune organs. NK1.1+ T cells are present within a population of intermediate TCR cells, J. Immunol., 155, 2972, 10.4049/jimmunol.155.6.2972

10.1084/jem.184.2.687